Author of the study is Christopher S., a general surgery resident at Loyola University Hospital. Corresponding Author Elizabeth J. Associate Director of the Burn & Shock Trauma Institute at Loyola University Chicago Stritch School of Medicine.

Why do some patients mount robust immune response in the lung, while others do not do? The reason could be. Due to age, genetics, differences in the patient’s underlying health conditions or anything that the balance between too much and too little inflammation can cause said Davis.Reference: C Chung et al. Cetuximab induced Anaphylactic reactions and IgE specific for of galactose-alpha-1,3 – galactose. New England Journal of Medicine DOI: 10.1056/NEJMoa074943 .

NIAID scholarship Thomas Platts-Mills, who heads the Department of Allergy and Clinical immunology to University of Virginia led a studies to study the cause the clinical problem with a cetuximab. Her newly registered intelligence are of immediate relevance for care for cancer patients, says Dr. Platts-Mills. Because of the widespread use of cetuximab in to cancer treatment, sense useful to identify patients at the screen specific IgE antibody specific IgE antibodies from cetuximab for those that are be at risk for severe adverse reactions, including anaphylaxis. .

Other articles from category "plastic surgery":

Random articles